NANOPEP, situated in Via Adige, Silvi, Italy, is an internationally recognized biotechnological company, specializing in the development and production of peptide bioregulation-based products. Boasting an array of biological supplements and vitamins, NANOPEP strives to improve human health and well-being by catering to adults of all ages who aspire to a healthy and vibrant lifestyle.

Leveraging over 30 years of experimental and clinical research by Professor Khavinson, NANOPEP is distinguished by its innovative peptide-based products known as KHAVINSON PEPTIDES®. These short peptides have emerged from meticulous research and development activities carried out by our dedicated team of scientists.
At the heart of our operations, peptides – short chains of amino acids found in all living organisms – serve a key role. These molecules, depending on the number of amino acids, can be classified as short peptides (2-4 amino acids), long peptides (5-50 amino acids), and proteins (>50 amino acids).

The distinguishing characteristics of short peptides, including their ability to quickly increase the cell count of any tissue, organ-specific effects, and safety, position them as a revolutionary product in the health industry. These short peptides have the power to activate the body's cell reserves at the DNA level, enhance the effectiveness of other biologically active components, increase the vital resources of organs and tissues, and facilitate the body's self-bioregulation.

With its commitment to bringing the benefits of cutting-edge biotechnology to the world, NANOPEP is proudly pioneering advancements in health supplements and vitamins, fueled by groundbreaking research and a passion for promoting health and wellness.